cox--derived prostacyclin confers atheroprotection female mice 
female gender affords relative protection cardiovascular disease menopause report estrogen acts estrogen receptor subtype alpha up-regulate production atheroprotective prostacyclin pgi activation cyclooxygenase cox- mechanism restrained oxidant stress platelet activation contribute atherogenesis female mice deletion pgi receptor removed atheroprotective effect estrogen ovariectomized female mice suggests chronic treatment patients selective inhibitors cox undermine protection cardiovascular disease premenopausal females 
